Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
Rev. Soc. Bras. Med. Trop
;
53: e20190150, 2020. tab
Article
in English
| LILACS
| ID: biblio-1057268
ABSTRACT
Abstract INTRODUCTION:
Benznidazole is used for treating Chagas disease (CD). This cross-sectional study aimed to characterize the adverse drug reactions (ADRs) of benznidazole at a public hospital in Brazil's Federal District.METHODS:
Medical records were analyzed and ADRs were categorized by type, intensity, seriousness, and causality.RESULTS:
Of the 62 patients who started benznidazole treatment for CD, 41 (66%) presented with 105 ADRs; 23 (37%) discontinued the treatment. Most reactions were classified as probable (81%), severe (63%), serious (67%), and dose-dependent (56%).CONCLUSIONS:
The high incidence of ADRs because of treatment withdrawal revealed the need for safer alternatives for CD treatment.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Trypanocidal Agents
/
Chagas Disease
/
Drug-Related Side Effects and Adverse Reactions
/
Nitroimidazoles
Type of study:
Incidence study
/
Observational study
/
Prevalence study
/
Prognostic study
/
Risk factors
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2020
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Universitário de Brasília/BR
/
Universidade de Brasília/BR
Similar
MEDLINE
...
LILACS
LIS